Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.

scientific article published on 14 November 2013

Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1183/09031936.00151313
P698PubMed publication ID24232704
P5875ResearchGate publication ID258528210

P50authorMarc HumbertQ33113039
José LabarereQ40833380
Martine Reynaud-GaubertQ42215588
Olivier SitbonQ57020181
François ChabotQ88878234
Jean-Luc CracowskiQ89692501
Ari ChaouatQ89807931
Gérald SimonneauQ98151102
Carole SchwebelQ114573953
Bruno DeganoQ117251152
Claire CracowskiQ117251173
P2093author name stringPatrice Faure
Azzedine Yaici
P433issue3
P304page(s)915-917
P577publication date2013-11-14
P1433published inEuropean Respiratory JournalQ12257435
P1476titleProinflammatory cytokine levels are linked to death in pulmonary arterial hypertension
P478volume43

Reverse relations

cites work (P2860)
Q36190169Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension
Q47741857Beneficial effects of bile acid receptor agonists in pulmonary disease models
Q42316663Chronic hypoxia aggravates monocrotaline-induced pulmonary arterial hypertension: a rodent relevant model to the human severe form of the disease.
Q60363740Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension
Q58273930Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
Q33839496Endothelial cell global positioning system for pulmonary arterial hypertension: homing in on vascular repair
Q92257238Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension
Q41922644Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension
Q52899598Gut-Lung Connection in Pulmonary Arterial Hypertension.
Q59309656Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?
Q33898213Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Q55155611Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.
Q92239221Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension
Q38525952Medical Therapies for the Treatment of Pulmonary Arterial Hypertension: How Do We Choose?
Q27023074Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course
Q48155147Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
Q90171107Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling
Q89860088Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
Q99635470Purinergic Dysfunction in Pulmonary Arterial Hypertension
Q50969268Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.
Q35165100Role of prostacyclin in pulmonary hypertension.
Q91792991SGK1 Mediates Hypoxic Pulmonary Hypertension through Promoting Macrophage Infiltration and Activation
Q64098812Schistosome infection and its effect on pulmonary circulation
Q89537347Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients
Q58801368The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
Q45046014The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension
Q92867422Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in mice
Q53767909[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].

Search more.